Skip to main content
Caplight Logo









Verily Health, Inc.

Verily Health, Inc.

Private
Dallas, TexasHealthcare & Life Scienceshttps://verily.com

Last Round

Corporate Funding

Extension

Sep 9, 2026

Total Funding Raised

$3.81B

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Verily Health, Inc. is a health technology company that provides a data platform and AI-enabled solutions to accelerate research and improve care.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Clinical Trials, Medical AI, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

precision healthclinical research platformAI health apphealth data analyticsAI agentclinical trial softwaredigital healthdata harmonizationbiomedical datacare transformationhealth techSaaSdata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Book a demo to explore historical pricing and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Book a demo

For institutional investors. Book with your work email.

Verily Health, Inc. Comparables

Compare Verily Health, Inc. with similar companies based on industry and business-model similarity.

Verily Health, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dassault Systèmes
79%
BC Platforms
77%
Innovaccer
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Verily Health, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate Funding ExtensionSep 9, 2026
Corporate FundingMar 19, 2026
GrantApr 30, 2025
Corporate FundingSep 9, 2022
Corporate FundingDec 17, 2020
Private Equity
Jan 3, 2019
Book a demo to see all 7 rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kristina Saffran

Cofounder And CEO

Founding Team

David Glazer

Workbench CTO

Executive Team

Jordan Owens

EBP to the Chief Technology Officer

Executive Team

Regan Rau

Strategy & Operations Lead, Office of the CTO

Executive Team

For institutional investors. Book with your work email.

Verily Health, Inc. Investors

Notable investors and investment history

Verily Health, Inc. investors
InvestorRounds
Series X CapitalCorporate Funding
TemasekCorporate Funding, Private Equity
Ontario Teachers' Pension PlanPrivate Equity, Corporate Funding
The Michael J. Fox Foundation for Parkinson's ResearchGrant
Silver LakeCorporate Funding, Private Equity
CU InnovationsCorporate Funding
Book a demo to see all investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2026

    New product named CareGuide is planned for strategic launch.

  • Oct 1, 2026

    AMP PD program is using Workbench for data infrastructure.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • launchesOct 20, 2026

    Verily Life Sciences LLC launches Project Baseline in United States to build real-world health evidence from continuous, multimodal data including genomics, imaging, wearable sensors, clinical encounters, and environmental factors.

  • signs_new_clientOct 6, 2026

    Verily Life Sciences LLC signs CDC as a new client under a contract awarded on Sep 28th '26 to test up to 200 public wastewater facilities twice weekly for influenza signals and feed the data into its public-health response system, with a first order worth up to $5.58 million in United States.

Book a demo to see all news

For institutional investors. Book with your work email.

Verily Health, Inc. Filings

Explore SEC and related filing metadata, where available.

Verily Health, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Verily Health, Inc.'s valuation, stock price, and market status.

Is Verily Health, Inc. a public or private company?

Verily Health, Inc. is a private company.

What is the current stock price of Verily Health, Inc.?

Verily Health, Inc. is a private company, so its shares have no public market price. Caplight tracks Verily Health, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Verily Health, Inc. worth (valuation)?

Valuation information for Verily Health, Inc. is not publicly available.

Can I buy Verily Health, Inc. stock?

Verily Health, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Verily Health, Inc.'s last funding round?

Verily Health, Inc.'s most recent funding round was Corporate Funding Extension on September 9, 2026.

Who are the main investors in Verily Health, Inc.?

Key investors in Verily Health, Inc. include Series X Capital, Temasek, Silver Lake.

Will Verily Health, Inc. IPO soon?

No public IPO plans have been announced for Verily Health, Inc..

How can I track Verily Health, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Verily Health, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersDallas, Texas
Employee Range1,105
Year Founded2015
Last FundingSep 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?